美联储后，美元未能突破欧元阻力，将暂停盘整。上周美联储鹰派降息对金融市场造成了冲击，波及股票、债券、货币、贵金属，甚至加密货币。美联储表示将采取长期限制性货币政策，这加剧了风险厌恶情绪，推动美元在本周结束时成为货币市场表现最强劲的货币，这得益于收益率飙升和美联储预期的提高。

Dollar to Pause for Consolidation After Failing to Break Euro Resistance Post-Fed.The financial markets were jolted by Fed's hawkish rate cut last week, sending ripples across stocks, bonds, currencies, precious metals, and even cryptocurrencies. Fed's indication of prolonged restrictive monetary policy fueled risk aversion, pushing Dollar to end the week as the strongest performer in the currency markets, supported by surging yields and elevated Fed expectations.

美元预测：DXY保持近2年高点，因美联储暗示2025年的降息减少。DXY本周上涨0.81%，因美联储暗示2025年降息减少，国债收益率攀升，通胀担忧持续存在。

US Dollar Forecast: DXY Holds Firm Near 2-Year High as Fed Signals Fewer 2025 Cuts.DXY rises 0.81% for the week as the Fed signals fewer 2025 rate cuts, Treasury yields climb, and inflation concerns persist.

在纽约，道琼斯指数周五上涨510点，涨幅1.21%。涨幅最大的是英伟达（2.46%）、联合健康（2.37%）和高盛（2.17%）。

In New York, the Dow Jones Index went up by 510 points or 1.21 percent on Friday. Top gainers were Nvidia (2.46%), UnitedHealth (2.37%) and Goldman Sachs (2.17%).

美国股市在今年最后三个转折日反弹，标准普尔500指数上涨1%，纳斯达克指数上涨0.8%，道琼斯指数上涨497点。此前通胀数据低于预期，11月个人消费支出指数同比增长2.4%，略低于预期。这有助于缓解美联储预测2025年降息减少引发的市场担忧。政府关门的威胁和关税威胁带来的全球市场压力也打压了市场情绪。诺和诺德（Novo Nordisk）的新型肥胖药物在测试中没有达到目标，导致这家制药巨头的不良反应（ADR）暴跌17.7%，医疗保健行业成为人们关注的焦点。反过来，竞争对手礼来公司的股价上涨了1.4%。考虑到本周，三大股指均下跌2.3%，道琼斯指数创下2023年以来最糟糕的一周。

US stocks bounced back on the last triple witching day of the year, with the S&P 500 up 1%, the Nasdaq rising 0.8% while the Dow gained 497 points. The rally followed cooler-than-expected inflation data, with November’s PCE index showing a 2.4% year-over-year increase, slightly below expectations. This helped alleviate market concerns sparked by the Federal Reserve’s forecast of fewer rate cuts in 2025. Sentiment was also weighed down by the threat of a government shutdown and global market pressure from tariff threats. The healthcare sector took the spotlight after Novo Nordisk’s new obesity drug missed targets in its test, driving the pharmaceutical giant’s ADRs to plunge 17.7%. In turn, equities for competitor Eli Lilly gained 1.4%. Considering the week, all the three major averages sank 2.3% with the Dow booked its worst week since 2023.